Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trial

Factors influencing life satisfaction in acute myeloid leukemia survivors following allogeneic stem cell transplantation: a cross-sectional study

Amler, S. (Susanne)
Sauerland, M.C. (Maria)
Deiters, C. (Christian)
Büchner, T. (Thomas)
Schumacher, A. (Andrea)

March 2015

Background: Allogeneic stem cell transplantation (alloSCT) is the preferred option of postremission ...

Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia

Zittoun, R.
Mandelli, F.
Willemze, R.
Witte, T. de
Labar, B.
Resegotti, L.
Leoni, F.
Damasio, E.
Visani, G.
Papa, G.
Caronia, F.
Hayat, M.
Stryckmans, P.
Rotoli, B.
Leoni, P.
Peetermans, M.E.
Dardenne, M.
Vegna, M.L.
Petti, M.C.
Solbu, G.
Suciu, S.

January 1995

Contains fulltext : 21388___.PDF (publisher's version ) (Open Access

Quality of Life in Long-Surviving Patients with Acute Leukemia (The Quality of Life in the Treatment of Cancer)

小池, 正
Koike, Tadashi

March 1997

Although the majority of adults with acute leukemia obtain a complete remission with current inducti...

Quality of life following allogeneic stem cell transplantation for patients age >60 years with acute myelogenous leukemia

Wright, Rachel
Oremek, Maximilian
Davies, David
Kewley, Caitlin
Singh, Alyssa
Taitt, Nathaniel
Kempshall, Emma
Wilson, Keith
Ingram, Wendy

August 2020

This study of patients with acute myelogenous leukemia (AML) age60 years analyzed the association be...

Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients: analysis of the UK Medical Research Council AML 10 Trial

Watson, M
Buck, G
Wheatley, K
Homewood, JR
Goldstone, AH
Rees, JKH
Burnett, AK

May 2004

The increasing success of intensive consolidation chemotherapy (CCT) as an alternative to bone marro...

Psychosocial, health and demographic characteristics of quality of life among patients with acute myeloid leukemia and malignant lymphoma who underwent autologous hematopoietic stem cell transplantation

Ladislav Slovacek
Birgita Slovackova
Ladislav Jebavy
Zuzana Macingova

CONTEXT AND OBJECTIVE: This study evaluated the effect of selected psychosocial, health and demograp...

Long-term follow-up of patients with acute myeloid leukemia surviving and free of disease recurrence for at least 2 years after autologous stem cell transplantation: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Czerw, T.
Labopin, M.
Gorin, N.C.
Giebel, S.
Blaise, D.
Meloni, G.
Pigneux, A.
Bosi, A.
Veelken, J.
Ferrara, F.
Schaap, N.P.
Lemoli, R.M.
Cornelissen, J.J.
Beohou, E.
Nagler, A.
Mohty, M.

January 2016

Contains fulltext : 170898.pdf (publisher's version ) (Closed access)BACKGROUND: L...

Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children Leukemia Group report

Entz-Werle, N
Suciu, S
van der Werff ten Bosch, J
Vilmer, E
Bertrand, Y
Benoit, Y
Margueritte, G
Plouvier, E
Boutard, P
Vandecruys, E
Ferster, A
Lutz, P
Uyttebroeck, Anne
Hoyoux, C
Thyss, A
Rialland, X
Norton, L
Pages, M-P
Philippe, N
Otten, J
Behar, C
EORTC Children Leukemia Group

December 2005

The first EORTC (European Organization of Research and Treatment of Cancer) acute myeloblastic leuke...

Treatment of acute myelogenous leukemia. An EBMT-EORTC retrospective analysis of chemotherapy versus allogeneic or autologous bone marrow transplantation

Hermans, Jo
Stijnen, Th
Suciu, Stefan
Aegerter, Philippe
Gorin, Norbert Claude
Gratwohl, Alois
Hayat, Marcel
Stryckmans, Pierre
Zittoun, Robert A.
Zwaan, Ferry F.E.

January 1989

In a retrospective analysis, patients with acute myelogenous leukemia (AML), treated in first comple...

Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients

Watson, M.
Buck, G.
Wheatley, K.
Homewood, J. R.
Goldstone, A. H.
Rees, J. K. H.
Burnett, Alan Kenneth

May 2004

The increasing success of intensive consolidation chemotherapy (CCT) as an alternative to bone marro...

RESEARCH Factors influencing life sat r

August 2016

Background protocols can cause somatic late effects as well as psy-Amler et al. Health and Quality o...

A Comparison of Quality of Life between Intense and Non-Intense Treatment for Patients with Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome

Tinsley, Sara Marie

September 2015

Acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS) are hematologic malignanci...

Forsythe A
Kwon CS
Bell T
Smith TA
Arondekar B

January 2019

Anna Forsythe,1 Christina S Kwon,1 Timothy Bell,2 T Alexander Smith,3 Bhakti Arondekar4 1Purple Squi...

Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients; analysis of the UK Medical Research Council AML 10 Trial.

Watson, M
Buck, G
Wheatley, K
Homewood, JR
Goldstone, A
Rees, J
Burnett, A

January 2004

The increasing success of intensive consolidation chemotherapy (CCT) as an alternative to bone marro...

急性白血病長期存活病患之「以存活時間加權後之健康品質」分析

Hsu, Chiun
許駿

June 2009

The objective of this study was to use survival-weighted psychometric scores (SWPS) to construct a ‘...

Factors influencing life satisfaction in acute myeloid leukemia survivors following allogeneic stem cell transplantation: a cross-sectional study

Amler, S. (Susanne)
Sauerland, M.C. (Maria)
Deiters, C. (Christian)
Büchner, T. (Thomas)
Schumacher, A. (Andrea)

March 2015

Background: Allogeneic stem cell transplantation (alloSCT) is the preferred option of postremission ...

Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia

Zittoun, R.
Mandelli, F.
Willemze, R.
Witte, T. de
Labar, B.
Resegotti, L.
Leoni, F.
Damasio, E.
Visani, G.
Papa, G.
Caronia, F.
Hayat, M.
Stryckmans, P.
Rotoli, B.
Leoni, P.
Peetermans, M.E.
Dardenne, M.
Vegna, M.L.
Petti, M.C.
Solbu, G.
Suciu, S.

January 1995

Contains fulltext : 21388___.PDF (publisher's version ) (Open Access

Quality of Life in Long-Surviving Patients with Acute Leukemia (The Quality of Life in the Treatment of Cancer)

小池, 正
Koike, Tadashi

March 1997

Although the majority of adults with acute leukemia obtain a complete remission with current inducti...

Quality of life following allogeneic stem cell transplantation for patients age >60 years with acute myelogenous leukemia

Wright, Rachel
Oremek, Maximilian
Davies, David
Kewley, Caitlin
Singh, Alyssa
Taitt, Nathaniel
Kempshall, Emma
Wilson, Keith
Ingram, Wendy

August 2020

This study of patients with acute myelogenous leukemia (AML) age60 years analyzed the association be...

Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients: analysis of the UK Medical Research Council AML 10 Trial

Watson, M
Buck, G
Wheatley, K
Homewood, JR
Goldstone, AH
Rees, JKH
Burnett, AK

May 2004

The increasing success of intensive consolidation chemotherapy (CCT) as an alternative to bone marro...

Psychosocial, health and demographic characteristics of quality of life among patients with acute myeloid leukemia and malignant lymphoma who underwent autologous hematopoietic stem cell transplantation

Ladislav Slovacek
Birgita Slovackova
Ladislav Jebavy
Zuzana Macingova

CONTEXT AND OBJECTIVE: This study evaluated the effect of selected psychosocial, health and demograp...

Long-term follow-up of patients with acute myeloid leukemia surviving and free of disease recurrence for at least 2 years after autologous stem cell transplantation: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Czerw, T.
Labopin, M.
Gorin, N.C.
Giebel, S.
Blaise, D.
Meloni, G.
Pigneux, A.
Bosi, A.
Veelken, J.
Ferrara, F.
Schaap, N.P.
Lemoli, R.M.
Cornelissen, J.J.
Beohou, E.
Nagler, A.
Mohty, M.

January 2016

Contains fulltext : 170898.pdf (publisher's version ) (Closed access)BACKGROUND: L...

Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children Leukemia Group report

Entz-Werle, N
Suciu, S
van der Werff ten Bosch, J
Vilmer, E
Bertrand, Y
Benoit, Y
Margueritte, G
Plouvier, E
Boutard, P
Vandecruys, E
Ferster, A
Lutz, P
Uyttebroeck, Anne
Hoyoux, C
Thyss, A
Rialland, X
Norton, L
Pages, M-P
Philippe, N
Otten, J
Behar, C
EORTC Children Leukemia Group

December 2005

The first EORTC (European Organization of Research and Treatment of Cancer) acute myeloblastic leuke...

Treatment of acute myelogenous leukemia. An EBMT-EORTC retrospective analysis of chemotherapy versus allogeneic or autologous bone marrow transplantation

Hermans, Jo
Stijnen, Th
Suciu, Stefan
Aegerter, Philippe
Gorin, Norbert Claude
Gratwohl, Alois
Hayat, Marcel
Stryckmans, Pierre
Zittoun, Robert A.
Zwaan, Ferry F.E.

January 1989

In a retrospective analysis, patients with acute myelogenous leukemia (AML), treated in first comple...

Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients

Watson, M.
Buck, G.
Wheatley, K.
Homewood, J. R.
Goldstone, A. H.
Rees, J. K. H.
Burnett, Alan Kenneth

May 2004

The increasing success of intensive consolidation chemotherapy (CCT) as an alternative to bone marro...

RESEARCH Factors influencing life sat r

August 2016

Background protocols can cause somatic late effects as well as psy-Amler et al. Health and Quality o...

A Comparison of Quality of Life between Intense and Non-Intense Treatment for Patients with Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome

Tinsley, Sara Marie

September 2015

Acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS) are hematologic malignanci...

Forsythe A
Kwon CS
Bell T
Smith TA
Arondekar B

January 2019

Anna Forsythe,1 Christina S Kwon,1 Timothy Bell,2 T Alexander Smith,3 Bhakti Arondekar4 1Purple Squi...

Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients; analysis of the UK Medical Research Council AML 10 Trial.

Watson, M
Buck, G
Wheatley, K
Homewood, JR
Goldstone, A
Rees, J
Burnett, A

January 2004

The increasing success of intensive consolidation chemotherapy (CCT) as an alternative to bone marro...

急性白血病長期存活病患之「以存活時間加權後之健康品質」分析

Hsu, Chiun
許駿

June 2009

The objective of this study was to use survival-weighted psychometric scores (SWPS) to construct a ‘...

Factors influencing life satisfaction in acute myeloid leukemia survivors following allogeneic stem cell transplantation: a cross-sectional study

Amler, S. (Susanne)
Sauerland, M.C. (Maria)
Deiters, C. (Christian)
Büchner, T. (Thomas)
Schumacher, A. (Andrea)

March 2015

Background: Allogeneic stem cell transplantation (alloSCT) is the preferred option of postremission ...

Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia

Zittoun, R.
Mandelli, F.
Willemze, R.
Witte, T. de
Labar, B.
Resegotti, L.
Leoni, F.
Damasio, E.
Visani, G.
Papa, G.
Caronia, F.
Hayat, M.
Stryckmans, P.
Rotoli, B.
Leoni, P.
Peetermans, M.E.
Dardenne, M.
Vegna, M.L.
Petti, M.C.
Solbu, G.
Suciu, S.

January 1995

Contains fulltext : 21388___.PDF (publisher's version ) (Open Access

Quality of Life in Long-Surviving Patients with Acute Leukemia (The Quality of Life in the Treatment of Cancer)

小池, 正
Koike, Tadashi

March 1997

Although the majority of adults with acute leukemia obtain a complete remission with current inducti...

Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trial

Abstract

Extracted data

Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trial

Abstract

Extracted data

Related items

Related items